Vaccinex, Inc.
NASDAQ:VCNX
1.18 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.052 | 0.232 | 0.104 | -0.386 | 0.02 | 0 | 0.55 | 0.05 | 0.05 | 0 | 0 | 0.85 | 0.05 | 0 | 0.85 | 0.05 | 0.05 | 0 | 0 | 0 | 0.404 | 0.025 | 0.094 | 0.194 | 0.198 | 0.126 | 0.206 | 0.09 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 3.864 | 0.027 | 0.027 | 0.031 | 0.03 | 0.031 | 0.045 | 0 | 0.054 | 0.041 | 0.041 | 3.629 | 0.035 | 5.513 | 0.002 | 0.002 | 4.519 | 5.409 | 4.411 | 0.008 | 0.016 | 0.175 | 0.301 | 0.246 | 0.246 | 0.24 | 0.16 | 0 | 0 | 0 |
| Gross Profit
| 0.052 | -3.632 | 0.077 | -0.413 | -0.011 | -0.03 | 0.519 | 0.005 | 0.05 | -0.054 | -0.041 | 0.809 | -3.579 | -0.035 | -4.663 | 0.048 | 0.048 | -4.519 | -5.409 | -4.411 | 0.396 | 0.009 | -0.081 | -0.107 | -0.048 | -0.12 | -0.034 | -0.07 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | -15.655 | 0.74 | 1.069 | -0.55 | 0 | 0.944 | 0.1 | 1 | 0 | 0 | 0.952 | -71.58 | 0 | -5.486 | 0.96 | 0.96 | 0 | 0 | 0 | 0.98 | 0.36 | -0.862 | -0.552 | -0.242 | -0.952 | -0.165 | -0.778 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.165 | 3.864 | 3.383 | 3.331 | 4.355 | 5.05 | 3.812 | 3.741 | 3.429 | 3.843 | 2.966 | 3.954 | 3.629 | 4.064 | 5.513 | 4.249 | 7.334 | 4.557 | 5.409 | 4.411 | 6.543 | 7.304 | 7.412 | 7.073 | 5.314 | 5.512 | 4.454 | 5.028 | 4.292 | 3.392 | 3.839 |
| General & Administrative Expenses
| 1.439 | 2.09 | 1.795 | 1.631 | 1.499 | 2.027 | 1.724 | 1.603 | 1.413 | 1.558 | 1.628 | 1.564 | 1.484 | 1.605 | 1.577 | 1.84 | 1.872 | 1.943 | 1.75 | 1.928 | 1.531 | 1.563 | 1.647 | 1.381 | 1.092 | 0.925 | 1.221 | 1.099 | 1.04 | 1.274 | 1.07 |
| Selling & Marketing Expenses
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.439 | 2.09 | 1.795 | 1.631 | 1.499 | 2.027 | 1.724 | 1.603 | 1.413 | 1.558 | 1.628 | 1.564 | 1.484 | 1.605 | 1.577 | 1.84 | 1.872 | 1.943 | 1.75 | 1.928 | 1.531 | 1.563 | 1.647 | 1.381 | 1.092 | 0.925 | 1.221 | 1.099 | 1.04 | 1.274 | 1.07 |
| Other Expenses
| 0 | 0 | -0.001 | -0.052 | 0.922 | 0.017 | 0.024 | -0.175 | 0.034 | 0.019 | 0 | -0.005 | -0.001 | 0.051 | -0.002 | -0.017 | -0.023 | -0.001 | 0.01 | 0.013 | 0.036 | 0.03 | 0.073 | 0.112 | 0.067 | 0 | -0.014 | -0.017 | 0 | -0.007 | -0.016 |
| Operating Expenses
| 4.604 | 5.954 | 5.178 | 4.962 | 5.854 | 7.077 | 5.536 | 5.169 | 4.842 | 5.401 | 4.594 | 5.518 | 5.113 | 5.669 | 7.09 | 6.089 | 8.631 | 6.5 | 7.159 | 6.339 | 8.074 | 8.867 | 9.059 | 8.454 | 6.406 | 6.437 | 5.675 | 6.127 | 5.332 | 4.666 | 4.909 |
| Operating Income
| -4.552 | -5.722 | -5.074 | -4.988 | -5.834 | -7.077 | -4.986 | -5.119 | -4.792 | -5.401 | -4.594 | -5.518 | -5.063 | -5.669 | -6.24 | -6.089 | -8.583 | -6.5 | -7.159 | -6.339 | -7.678 | -8.858 | -9.14 | -8.561 | -6.454 | -6.557 | -5.709 | -6.197 | -5.332 | -4.666 | -4.909 |
| Operating Income Ratio
| -87.538 | -24.664 | -48.788 | 12.922 | -291.7 | 0 | -9.065 | -102.38 | -95.84 | 0 | 0 | -6.492 | -101.26 | 0 | -7.341 | -121.78 | -171.66 | 0 | 0 | 0 | -19.005 | -354.32 | -97.234 | -44.129 | -32.596 | -52.04 | -27.714 | -68.856 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.18 | 0.091 | 1.177 | 1.671 | 0.922 | 0.017 | 0.024 | 0.041 | 0.033 | 0.018 | -0.001 | 0.887 | -0.143 | -0.3 | -0.334 | -0.356 | -0.171 | -0.001 | 0.01 | 0.013 | 0.036 | 0.03 | 0.073 | 0.112 | -0.145 | -0.051 | -2.153 | 3.57 | -0.204 | -0.213 | -0.808 |
| Income Before Tax
| -5.732 | -5.631 | -3.897 | -3.317 | -4.912 | -7.06 | -4.962 | -5.078 | -4.759 | -5.383 | -4.595 | -4.631 | -5.206 | -5.969 | -6.574 | -6.445 | -8.754 | -6.501 | -7.149 | -6.326 | -7.642 | -8.828 | -9.067 | -8.449 | -6.599 | -6.608 | -7.862 | -2.627 | -5.536 | -4.879 | -5.717 |
| Income Before Tax Ratio
| -110.231 | -24.272 | -37.471 | 8.593 | -245.6 | 0 | -9.022 | -101.56 | -95.18 | 0 | 0 | -5.448 | -104.12 | 0 | -7.734 | -128.9 | -175.08 | 0 | 0 | 0 | -18.916 | -353.12 | -96.457 | -43.552 | -33.328 | -52.444 | -38.165 | -29.189 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0.027 | 0.038 | -0.031 | 0.017 | -0.024 | -0.059 | 0.035 | -0.018 | 0.001 | -0.016 | 0.141 | 0.402 | 0.33 | 0.322 | 0.125 | 0 | 0 | 0.013 | 0.036 | 0.03 | 0.073 | 0.112 | 0.111 | 0.081 | 0.253 | 0.316 | 0.361 | 0.348 | 0.256 |
| Net Income
| -5.732 | -5.631 | -3.897 | -3.317 | -4.912 | -7.06 | -4.938 | -5.019 | -4.759 | -5.365 | -4.596 | -4.631 | -5.206 | -5.969 | -6.574 | -6.445 | -8.754 | -6.501 | -7.149 | -6.326 | -7.642 | -8.828 | -9.067 | -8.449 | -6.599 | -6.608 | -7.862 | -2.59 | -5.536 | -4.879 | -5.717 |
| Net Income Ratio
| -110.231 | -24.272 | -37.471 | 8.593 | -245.6 | 0 | -8.978 | -100.38 | -95.18 | 0 | 0 | -5.448 | -104.12 | 0 | -7.734 | -128.9 | -175.08 | 0 | 0 | 0 | -18.916 | -353.12 | -96.457 | -43.552 | -33.328 | -52.444 | -38.165 | -28.778 | 0 | 0 | 0 |
| EPS
| -2.83 | -3.1 | -2.94 | -8.44 | -15.26 | -25.2 | -20.9 | -23.08 | -23.42 | -27.21 | -25.21 | -32.41 | -35.49 | -43.86 | -54.75 | -60.46 | -91.57 | -81.8 | -93.83 | -89.86 | -116.63 | -161.5 | -165.92 | -153.69 | -195.77 | -172.76 | -289.69 | -95.43 | -203.99 | -179.78 | -210.66 |
| EPS Diluted
| -2.83 | -3.1 | -2.94 | -8.44 | -15.26 | -24.54 | -20.79 | -23.08 | -23.42 | -26.41 | -24.9 | -31.57 | -35.49 | -43.86 | -54.75 | -60.46 | -91.57 | -81.8 | -93.83 | -89.86 | -116.63 | -161.5 | -165.92 | -153.69 | -195.77 | -172.76 | -289.69 | -95.43 | -203.99 | -179.78 | -210.66 |
| EBITDA
| -5.708 | -5.606 | -3.842 | -3.396 | -4.881 | -7.03 | -4.931 | -5.033 | -4.691 | -5.328 | -4.553 | -4.59 | -5.027 | -5.583 | -6.187 | -6.036 | -8.532 | -6.413 | -7.074 | -6.258 | -7.578 | -8.801 | -9.08 | -8.392 | -6.501 | -6.471 | -7.539 | -2.203 | -5.278 | -4.474 | -5.397 |
| EBITDA Ratio
| -109.769 | -24.164 | -48.788 | 12.854 | -291.7 | 0 | -8.965 | -100.66 | -93.82 | 0 | 0 | -5.419 | -100.54 | 0 | -7.279 | -120.72 | -170.62 | 0 | 0 | 0 | -18.757 | -350.84 | -95.819 | -43.258 | -31.985 | -51.595 | -27.51 | -68.444 | 0 | 0 | 0 |